Aletho News

ΑΛΗΘΩΣ

FDA Approves Remdesivir in Kidney Patients after Failed Trial

By Peter A. McCullough, MD, MPH | Courageous Discourse | July 21, 2023

In a move that defies all regulatory convention, the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury® (remdesivir) in COVID-19 patients with severe renal impairment, including those on dialysis. With this approval, Veklury is now the first and only approved antiviral COVID-19 treatment that can be used across all stages of renal disease but has no efficacy data to support its administration.

Gilead: July 14, 2023 FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis

The phase 3 REDPINE trial failed to recruit sufficient subjects to assess efficacy. Instead of properly rejecting the application, the FDA went ahead and approved the drug with insufficient safety and efficacy data. The drug has struggled in recent years as patients commonly decline the antiviral since the November, 2020, WHO warning against inpatient use. Remdesivir can cause both kidney injury and liver damage, thus with no mortality benefit, many believe it should not be used.

The FDA approval action defies logic and will be added to a long list of acts that will be considered malfeasance and will be up for review when the commissioner and agency is finally called to justice.

July 22, 2023 - Posted by | Timeless or most popular, War Crimes |

1 Comment »

  1. Every single one of the people involved with approving these deadly “covid countermeasures” (Remdesivir, vaccines, lockdowns, forced masking, hospital kickbacks etc..) should be prosecuted and on death row awaiting execution. They knew exactly what they were doing

    Like

    tammymartin12767's avatar Comment by tammymartin12767 | July 22, 2023 | Reply


Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.